rss
Br J Ophthalmol 2004;88:708-713 doi:10.1136/bjo.2003.032250
  • Perspective

Cannabinoids and glaucoma

  1. I Tomida1,
  2. R G Pertwee2,
  3. A Azuara-Blanco1
  1. 1Department of Ophthalmology, Aberdeen Royal Infirmary, University of Aberdeen, UK
  2. 2Department of Biomedical Sciences, Institute of Medical Sciences, University of Aberdeen, UK
  1. Correspondence to: A Azuara-Blanco PhD FRCS(Ed), The Eye Clinic, Aberdeen Royal Infirmary, Aberdeen AB25 2ZN, UK; Aazblancoaol.com
  • Accepted 4 October 2003

Abstract

Glaucoma is one of the leading causes of blindness in the world. In spite of the diverse therapeutic possibilities, new and better treatments for glaucoma are highly desirable. Cannabinoids effectively lower the intraocular pressure (IOP) and have neuroprotective actions. Thus, they could potentially be useful in the treatment of glaucoma. The purpose of this article is to provide the reader with an overview of the latest achievements in research into the potential use of cannabinoids for glaucoma.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Social bookmarking

    Register for free content


    Free sample
     This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
    View free sample issue >>

    Free archive
    The full back archive is now available for BJO. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
    Register to access the free archive >>

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.